Both in Pharmaceuticals
Rapport Therapeutics vs Mineralys Therapeutics
Over the past year RAPP returned −5.6% and MLYS returned −59.2%; their daily moves had a correlation of 0.27.
RAPP −5.6% MLYS −59.2%Growth of $1, one year, split-adjusted
| Metric | RAPP | MLYS |
|---|---|---|
| Price | $25.44 | $15.99 |
| Market cap | $1.43B | $1.41B |
| Today | +1.23% | +2.83% |
| 1 month | −21.0% | −31.4% |
| 6 months | −28.5% | −45.4% |
| Year to date | −16.2% | −55.9% |
| 1 year | −12.1% | −60.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 71.6× | — |
| Net cash | $436.1M | $563.8M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 72.4% |
| Short % of float | 10.9% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).